CNS & Neurological Disorders - Drug Targets
Title:Meet Our Editorial Board Member
Volume: 17 Issue: 1
Author(s): Laszlo Vecsei
Affiliation:
Export Options
About this article
Cite this article as:
Vecsei Laszlo , Meet Our Editorial Board Member, CNS & Neurological Disorders - Drug Targets 2018; 17 (1) . https://dx.doi.org/10.2174/187152731701180426141109
DOI https://dx.doi.org/10.2174/187152731701180426141109 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
37
2
1
2
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Meta-analysis Identifies Tumor Necrosis Factor-alpha and Interleukin-1 beta as Diagnostic Biomarkers for Bacterial and Aseptic Meningitis
Current Neurovascular Research Omega-3 Fatty Acids and Hippocampal Neurogenesis in Depression
CNS & Neurological Disorders - Drug Targets Allosteric Modulation of Muscarinic Acetylcholine Receptors
Current Neuropharmacology Human Telomere RNA: A Potential Target for Ligand Recognition
Current Pharmaceutical Design Foreword
Neuroscience and Biomedical Engineering (Discontinued) Estrogen Deprivation and Myocardial Infarction: Role of Aerobic Exercise Training, Inflammation and Metabolomics
Current Cardiology Reviews Cortical Consequences of HIV-1 Tat Exposure in Rats are Enhanced by Chronic Cocaine
Current HIV Research Modulation of the Immune System for the Treatment of Glaucoma
Current Neuropharmacology Pharmacological Characteristics of Parenteral IGF-I Administration
Current Pharmaceutical Biotechnology From the Table to the Bedside: Can Food-Derived Sulforaphane be used as a Novel Agent to Treat Leukemia?
Current Cancer Drug Targets Catechol-O-Methyl Transferase Modulates Cognition in Late Life: Evidence and Implications for Cognitive Enhancement
CNS & Neurological Disorders - Drug Targets Pleiotropic Effect of Mahanine and Girinimbine Analogs: Anticancer Mechanism and its Therapeutic Versatility
Anti-Cancer Agents in Medicinal Chemistry Targeting Signal Transduction Pathways in the Treatment of Mood Disorders: Recent Insights into the Relevance of the Wnt Pathway
CNS & Neurological Disorders - Drug Targets Methods for Detection of Speech Impairment Using Mobile Devices
Recent Patents on Signal Processing (Discontinued) Neprilysin and Amyloid Beta Peptide Degradation
Current Alzheimer Research Liquiritigenin Decreases Selective Molecular and Behavioral Effects of Cocaine in Rodents
Current Neuropharmacology A Comparison of Non-Human Primate Cytochrome P450 2D Members and the Implication in Drug Discovery
Current Drug Metabolism Adherence to Cardiac Practice Guidelines in the Management of Non-ST-Elevation Acute Coronary Syndromes: A Systematic Literature Review
Current Cardiology Reviews 6-Oxo-Morphinane Oximes: Pharmacology, Chemistry and Analytical Application
Current Medicinal Chemistry Advanced Glycation End Products, Oxidative Stress and Metalloproteinases are altered in the Cerebral Microvasculature during Aging
Current Neurovascular Research